Abstract
Our experiences of managing nocturnal enuresis in Greek children at our Outpatient Clinics of Pediatric Urology are described. Between March 2001 and October 2003, 142 children with primary nocturnal enuresis (93 boys and 49 girls), aged 7–18 years old (mean: 9.0±0.5) were included in this prospective study. Initially, behavioral conditioning therapy, using a body-worn urinary alarm, was instructed in all cases. If no improvement was recorded, 40 μg of intranasal desmopressin was administered, initially for three months. If urodynamic studies demonstrated pure detrusor instability, anticholinergics (5 mg oxybutinine or 2 mg tolterodine) were given instead. Combination medication (desmopressin and anticholinergics) was administered for coexisting diurnal enuresis, which was present in 8 children. Among the 142 children the overall response rate was 51.41%. Successful response was recorded in 16 children practicing conditioning behavioral therapy, in 47 receiving desmopressin (with or without anticholinergics), and in 10 children receiving only anticholinergics. During the follow-up period (mean: 6.2 months), no serious side effect was recorded. The use of desmopressin, and anticholinergics in specific subgroups, was found to be effective and safe for the management of nocturnal enuresis in children.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Yeung CK (2003) Nocturnal enuresis (bedwetting). Curr Opin Urol 13:337–343
Kuznetsova AA, Shakhmatova EI, Prutskova NP, Natochin YV (2000) Possible role of prostaglandins in pathogenesis of noctural enuresis in children. Scand J Urol Nephrol 34:27–31
Bauer SB, Koff SA, Jayanthi VR (2002) Voiding dysfunction in children: neurogenic and non-neurogenic. In: Walsh PC, Retik AB, Vaughan ED, Wein AJ (eds) Campbell’s urology. Saunders, Philadelphia, PA, pp 2261–2283
Hjalmas K (2002) Enuresis in children. Braz J Urol 28:232–249
Nørgaard JP, Pedersen EB, Djurhuus JC (1985) Diurnal anti-diuretic hormone levels in enuretics. J Urol 134:1029–1031
Moffatt ME, Harlos S, Kirshen AJ, Burd L (1993) Desmopressin acetate and nocturnal enuresis—how much do we know? Pediatrics 92:420–425
Riccabona M, Oswald J, Glauninger P (1998) Long-term use and tapered dose reduction of intranasal desmopressin in the treatment of enuretic children. Br J Urol 81(Suppl 3):24–25
Hjalmas K, Sillen U, Hanson E, Kruse S, Hellstrom A (1998) Long-term treatment with desmopressin of children with primary monosymptomatic nocturnal enuresis—an open multicentre study. Brit J Urol 82:704–709
Wolfish NM, Barkin J, Gorodzinsky F, Schwarz R (2003) The Canadian Enuresis Study and Evaluation—short- and long-term safety and efficacy of an oral desmopressin preparation. Scand J Urol Nephrol 37:22–27
Cigna RM, Chiaramonte C, Piscopo A, Cataliotti F (2002) Urodynamic evaluation in children with enuresis. Pediatr Med Chir 24:363–367
Acknowledgements
We would like to thank Dr. Grigorios Tripsianis, Associate Professor of Medical Statistics, for his valuable help in analyzing the data.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Triantafyllidis, A., Charalambous, S., Papatsoris, A.G. et al. Management of nocturnal enuresis in Greek children. Pediatr Nephrol 20, 1343–1345 (2005). https://doi.org/10.1007/s00467-005-1921-x
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00467-005-1921-x